<img height="1" width="1" src="https://www.facebook.com/tr?id=200201724533423&amp;ev=PageView &amp;noscript=1">
Contact Us

    GENOMIND PRESS ROOM

    March 25, 2020

    Helping You Shift to Telepsychiatry in the Era of COVID-19

    Recent government actions enable telepsychiatry

    Continue Reading...
    March 19, 2020

    Genomind Launches Express Ship-to-Patient Capability for Genomind Professional PGx Express Test Enabling Access to Critical Mental Health Treatment Information

    As the first company to offer direct-to-patient, at-home mental health pharmacogenetic testing, Genomind is helping patients and physicians gain actionable mental health insights without having to leave their homes

    Continue Reading...
    March 10, 2020

    Genomind Substantially Increases Customer Access to Pharmacogenetic Mental Health Testing Through Expanded Partnership With Jewel-Osco

    Latest agreement quadruples number of pharmacies in Albertsons Companies offering Genomind’s tests and services

    Continue Reading...
    December 16, 2019

    Genomind Expands Collaboration to Provide Access to Genetics-Based Mental Health Test to Customers in All Pennsylvania ACME Markets

    Specially trained ACME pharmacists will identify and work with patients who may benefit from Genomind Professional PGx Express – the most comprehensive genetic testing service aimed at improving mental health treatments

    Continue Reading...
    December 9, 2019

    Genomind Joins Forces With Sharecare to Improve Mental Health Outcomes

    Genomind brings expertise in mental health education and pharmacogenomics services to Sharecare’s comprehensive digital health platform

    Continue Reading...
    November 7, 2019

    Genomind Bolsters Medicare Reimbursement Initiatives, Obtaining Z-Codes for Genomind Professional PGx Express

    Designation critical step for Medicare local coverage determinant under the Molecular Diagnostic Services (MolDX) program

    Continue Reading...

    SEARCH NEWS